Erythropoietin

Erythropoietin (EPO) is a hormone produced naturally by your kidneys. It stimulates the production of red blood cells in your bone marrow, which are essential for carrying oxygen throughout your body. EPO is also available in recombinant form as a medication, commonly known as Epogen or Procrit, to treat anemia caused by various medical conditions.
In people with chronic kidney disease or on dialysis, EPO deficiency can lead to anemia due to decreased kidney function. By replacing the missing hormone, EPO medication helps raise the red blood cell count, improving the ability to carry oxygen and reduce the feelings of fatigue.
Erythropoietin is also prescribed to individuals with anemia resulting from cancer treatments, such as radiation or chemotherapy. Cancer itself can affect the bone marrow and reduce the production of red blood cells. EPO therapy can assist in increasing the red blood cell levels, improving the quality of life and ability to tolerate further treatment.
However, it is vital to monitor EPO therapy and its effects on the body. Overly high red blood cell counts could increase the risk of blood clots or damage to the heart, liver, and kidneys. Therefore, a healthcare professional will closely monitor a patient’s response to EPO treatment to ensure the appropriate dosage and avoid potential complications.